Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 2,738 | 2,186 | 2,569 | 1,971 | 4,544 |
| Cost of Goods | 1,588 | 1,191 | 1,296 | 1,041 | 2,504 |
| Gross Profit | 1,150 | 995 | 1,273 | 930 | 2,040 |
| Operating Expenses | 2,629 | 1,715 | 1,980 | 1,802 | 3,222 |
| Operating Income | -891 | -529 | -412 | -831 | -678 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 37 | 304 | 242 | 206 | 600 |
| Pre-tax Income | -854 | -226 | -170 | -625 | -80 |
| Income Tax | 25 | -3 | N/A | 4 | -759 |
| Net Income Continuous | -879 | -223 | -170 | -629 | 680 |
| Net Income | $-873 | $-228 | $-170 | $-629 | $680 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.01 | -0.03 | 0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.01 | -0.03 | 0.03 |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.01 | -0.03 | 0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.01 | -0.03 | 0.02 |
| EBITDA(a) | $-622 | $-304 | $-210 | $-619 | $-418 |